Ariosa Diagnostics, Inc. to Present at the J.P. Morgan 31st Annual Healthcare Conference
Published: Dec 19, 2012
SAN JOSE, Calif., Dec. 19, 2012 /PRNewswire/ -- Ariosa Diagnostics, maker of the Harmony Prenatal Test, today announced that it will present at the 31st Annual JP Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Wednesday, Jan 9.
Dr. Ken Song, CEO of Ariosa Diagnostics, will provide an update on the company and its product portfolio at 3:00 p.m. in the Elizabethan CD 120 Room.
About Ariosa Diagnostics
Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to innovating together to improve patient care. The flagship product, the Harmony Prenatal Test, is a safe, highly accurate and affordable prenatal test for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. The Harmony test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.
The company began operations in 2010 and is headquartered in San Jose, Calif. For more information, visit www.ariosadx.com.
SOURCE Ariosa Diagnostics